Rob Seaman

Rob obtained his MS in Pharmacology and Toxicology from the University at Buffalo and his PhD in Integrated Biomedical Sciences with a focus in Physiology and Pharmacology from the University of Texas Health Science Center at San Antonio. His pre-clinical research focuses on evaluating novel immunotherapeutics targeting commonly misused drugs and drug mixtures. In his free time, Rob likes to watch the Buffalo Bills and spend time with family.